Results 31 to 40 of about 482,170 (194)

Assessing the Impact of Rilonacept on Lipid Profiles in Patients With Recurrent Pericarditis. [PDF]

open access: yesJACC Adv
Bayat A   +6 more
europepmc   +2 more sources

Recurrent pericarditis : new and emerging therapeutic options

open access: yes, 2016
Recurrent pericarditis is one of the most common and troublesome complications after an episode of pericarditis, and affects 20-50% of patients treated for pericarditis.
Imazio M.   +13 more
core   +2 more sources

A risk score for pericarditis recurrence

open access: yesEuropean Journal of Clinical Investigation, 2021
AbstractBackgroundCurrently, we remain uncertain about which patients are at increased risk for recurrent pericarditis. We developed a risk score for pericarditis recurrence in patients with acute pericarditis.Materials and methodsWe prospectively recruited 262 patients with a first episode of acute pericarditis.
Emilia Lazarou   +10 more
openaire   +4 more sources

Meta-analysis for the value of colchicine for the therapy of pericarditis and of postpericardiotomy syndrome

open access: yesBMC Cardiovascular Disorders, 2019
Background Colchicine has been used as anti-inflammatory agent in pericardial effusion (PE). We sought to perform a meta-analysis of randomized trials assessing the efficacy and safety of colchicine in patients with pericarditis or postpericardiotomy ...
Leon L. Lutschinger   +6 more
doaj   +1 more source

Acute and Recurrent Pericarditis

open access: yesCardiology Clinics, 2017
Acute and recurrent pericarditis is the most common pericardial syndrome encountered in clinical practice either as an isolated process or as part of a systemic disease. The diagnosis is based on clinical evaluation, electrocardiogram, and echocardiography.
Imazio M, Gaita F
openaire   +4 more sources

Usefulness of Interleukin-1 Receptor Antagonists in Patients With Recurrent Pericarditis

open access: yes, 2020
Nonsteroidal anti-inflammatory drugs and colchicine remain the standard of care as the initial treatment of acute pericarditis. Corticosteroids and traditional immunosuppressive medications are often added if patients develop recurrent symptoms and ...
Verma B. R.   +8 more
core   +1 more source

A Brief Overview of Recurrent Pericarditis Management and the Potential of Rilonacept as a New Therapeutic Option

open access: yes, 2021
Recurrent pericarditis affects 15-30% of patients after acute pericarditis. A large number of the patients with recurrent pericarditis can become corticosteroid dependent, leading to disease chronicity and drug dependence, with additional morbidity from ...
Gupta, Manasvi   +13 more
core   +1 more source

Expanding the Patient Pool for Rilonacept

open access: yesJACC: Case Reports
Recurrent pericarditis complicates 15%-30% of acute pericarditis cases despite initial anti-inflammatory treatment. The RHAPSODY trial (Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis) showed ...
Emma St. John, MD   +9 more
doaj   +1 more source

Recurrent Pericarditis [PDF]

open access: yesCirculation, 2005
Recurrence is a serious complication of acute pericarditis, characterized by a return of pericardial pain after recovery from an attack of typical acute pericarditis. Some patients experience only a single recurrence, but in many less fortunate, pericardial pain returns unexpectedly at variable intervals during a period that may extend over many years.
openaire   +1 more source

Efficacy of an interleukin-1 beta receptor antagonist (Anakinra) in idiopathic recurrent pericarditis

open access: yes, 2012
Pericarditis may recur in up to 30 % of adult patients, but recurrent pericarditis is a rare disease in childhood. The etiology of the initial attack and the causes of recurrences often remain unknown.
Chiarelli F.   +7 more
core   +2 more sources

Home - About - Disclaimer - Privacy